Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...

Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology ...

Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...

Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.

Event driven snapshot of Recursion Pharmaceuticals Recursion Pharmaceuticals (RXRX) shares have been drawing attention after ...

Holding signs and banners reading Stop the AI Race and Don’t Build Skynet, the protesters marched through the city and gave ...

New programming expands hospitality model and diversifies revenue streams amid shifting direct-to-consumer landscape. April 1 ...

Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...

There is something almost disarmingly sincere about youth orchestras; an openness of gesture, a lack of defensive irony, that ...

Arka Mazumder hails from a middle-class family and had to also take education loans. Now, however, with a lucrative job, he ...

Evotec SE (NASDAQ:EVO) Q4 2025 Earnings Call Transcript April 8, 2026 Evotec SE reports earnings inline with expectations. Reported EPS is $0.2098 EPS, expectations were $0.2098. Operator: Ladies and ...

Faculty members at Northeast Community College are beginning to integrate artificial intelligence tools into their classrooms ...